Literature DB >> 10874522

Tremor-predominant Parkinson's disease. Approaches to treatment.

J Marjama-Lyons1, W Koller.   

Abstract

Parkinson's disease is a neurodegenerative disorder that manifests clinically with variable degrees of tremor, muscle rigidity, bradykinesia and postural instability. Tremor-predominant Parkinson's disease is characterised by prominent tremor of one or more limbs with a relative lack of significant rigidity and bradykinesia. Despite the lack of other disabling motor symptoms, the tremor of tremor-predominant Parkinson's disease can be very disabling, especially if a postural and kinetic component exists. A wide variety of treatments for Parkinson's disease tremor are currently available and include use of oral medications, injections with botulinum toxin and neurosurgical procedures. Some of the first line medications (levodopa, dopamine agonists, anticholinergics) are very effective in controlling tremor. However, some patients with Parkinson's disease tremors are unresponsive to first line drugs and treatment with second line medications (clozapine, amantadine, clonazepam, propranolol, neurontin) should be attempted. In the small number of patients with disabling tremor that is refractory to all medications, neurosurgical intervention should be considered. Both thermocoagulation and deep brain stimulation at several different neuroanatomical sites (thalamus, globus pallidus, subthalamic nucleus) offer good to excellent tremor control with relatively low risk to the patient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874522     DOI: 10.2165/00002512-200016040-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  40 in total

1.  High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease.

Authors:  R Pahwa; S Wilkinson; D Smith; K Lyons; E Miyawaki; W C Koller
Journal:  Neurology       Date:  1997-07       Impact factor: 9.910

2.  Functional neurosurgery with the Leksell Gamma knife.

Authors:  R F Young
Journal:  Stereotact Funct Neurosurg       Date:  1996       Impact factor: 1.875

3.  Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients.

Authors:  S L Pullman; P Greene; S Fahn; S F Pedersen
Journal:  Arch Neurol       Date:  1996-07

4.  Treatment of essential and parkinsonian tremor with nipradilol.

Authors:  F Yoshii; Y Shinohara; T Takeoka; Y Kitagawa; K Akiyama; K Yazaki
Journal:  Intern Med       Date:  1996-11       Impact factor: 1.271

5.  The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson's disease. A 10-year follow-up study.

Authors:  P J Kelly; F J Gillingham
Journal:  J Neurosurg       Date:  1980-09       Impact factor: 5.115

Review 6.  Dopamine agonists in the treatment of Parkinson's disease.

Authors:  R Pahwa; W C Koller
Journal:  Cleve Clin J Med       Date:  1995 Jul-Aug       Impact factor: 2.321

7.  Adjuvant therapy of parkinsonian tremor.

Authors:  W C Koller; G Herbster
Journal:  Arch Neurol       Date:  1987-09

8.  Botulinum toxin A injections for the treatment of hand tremors.

Authors:  R M Trosch; S L Pullman
Journal:  Mov Disord       Date:  1994-11       Impact factor: 10.338

9.  Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease.

Authors:  A Laihinen; U K Rinne; I Suchy
Journal:  Acta Neurol Scand       Date:  1992-12       Impact factor: 3.209

10.  Dopamine: release from the brain in vivo by amantadine.

Authors:  P F Von Voigtlander; K E Moore
Journal:  Science       Date:  1971-10-22       Impact factor: 47.728

View more
  27 in total

Review 1.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

2.  Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.

Authors:  Gaetano Barbagallo; Maria Eugenia Caligiuri; Gennarina Arabia; Andrea Cherubini; Angela Lupo; Rita Nisticò; Maria Salsone; Fabiana Novellino; Maurizio Morelli; Giuseppe Lucio Cascini; Domenico Galea; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2017-06-20       Impact factor: 5.038

3.  Motor subtype changes in early Parkinson's disease.

Authors:  Robert S Eisinger; Christopher W Hess; Daniel Martinez-Ramirez; Leonardo Almeida; Kelly D Foote; Michael S Okun; Aysegul Gunduz
Journal:  Parkinsonism Relat Disord       Date:  2017-07-21       Impact factor: 4.891

4.  The relationship between clinical phenotype and early staged bilateral deep brain stimulation in Parkinson disease.

Authors:  Victor W Sung; Ray L Watts; Christian J Schrandt; Stephanie Guthrie; Deli Wang; Amy W Amara; Barton L Guthrie; Harrison C Walker
Journal:  J Neurosurg       Date:  2013-09-27       Impact factor: 5.115

5.  Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease.

Authors:  Muhammet Ay; Jie Luo; Monica Langley; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  J Neurochem       Date:  2017-05-09       Impact factor: 5.372

6.  Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease.

Authors:  M M Lewis; G Du; S Sen; A Kawaguchi; Y Truong; S Lee; R B Mailman; X Huang
Journal:  Neuroscience       Date:  2011-01-04       Impact factor: 3.590

7.  White matter microstructure damage in tremor-dominant Parkinson's disease patients.

Authors:  ChunYan Luo; Wei Song; Qin Chen; Jing Yang; QiYong Gong; Hui-Fang Shang
Journal:  Neuroradiology       Date:  2017-05-24       Impact factor: 2.804

8.  Both coordination and symmetry of arm swing are reduced in Parkinson's disease.

Authors:  Xuemei Huang; Joseph M Mahoney; Mechelle M Lewis; Stephen J Piazza; Joseph P Cusumano
Journal:  Gait Posture       Date:  2011-11-17       Impact factor: 2.840

Review 9.  Therapeutic potential of cannabinoids in CNS disease.

Authors:  J Ludovic Croxford
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Default mode network differences between rigidity- and tremor-predominant Parkinson's disease.

Authors:  Prasanna R Karunanayaka; Eun-Young Lee; Mechelle M Lewis; Suman Sen; Paul J Eslinger; Qing X Yang; Xuemei Huang
Journal:  Cortex       Date:  2016-05-06       Impact factor: 4.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.